Ménière's disease and allergy: Epidemiology, pathogenesis, and therapy

Clin Exp Med. 2023 Nov;23(7):3361-3371. doi: 10.1007/s10238-023-01192-0. Epub 2023 Sep 24.

Abstract

The etiology of Ménière's disease (MD) remains controversial. Allergies are potential extrinsic factors that, in conjunction with underlying intrinsic factors, may cause MD. The link between allergies and MD was first described in 1923. For nearly a century, studies have demonstrated a possible link between allergies and MD, even though a causal relationship has not been definitively determined. Previous reviews have mainly focused on clinical epidemiology studies of patients. In this review, we shed light on the association between allergies and MD not only in terms of its epidemiology, but also from an immunology, pathophysiology, and immunotherapy perspective in both patients and animal models. Patients with MD tend to have a high risk of comorbid allergies or an allergy history, showing positive allergy immunology characteristics. Other MD-related diseases, such as migraine, may also interact with allergies. Allergy mediators such as IgE may worsen the symptoms of MD. Deposits of IgE in the vestibular end organs indicate the ability of the inner ear to participate in immune reactions. Allergic challenges can induce vertigo in animals and humans. Anti-allergy therapy plays a positive role in patients with MD and animal models of endolymphatic hydrops.

Keywords: Allergy; Endolymphatic hydrops; Ménière’s disease; Vertigo; Vestibular disease.

Publication types

  • Review

MeSH terms

  • Animals
  • Endolymphatic Hydrops* / diagnosis
  • Endolymphatic Hydrops* / etiology
  • Humans
  • Hypersensitivity* / complications
  • Hypersensitivity* / epidemiology
  • Hypersensitivity* / therapy
  • Immunoglobulin E
  • Immunotherapy
  • Meniere Disease* / epidemiology
  • Meniere Disease* / etiology
  • Meniere Disease* / therapy

Substances

  • Immunoglobulin E